All In Biotech

Free tool

FAERS Monitor: Jaypirca

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216059 or its brand name (Jaypirca, Pirtobrutinib). Reports on generic versions are filed under their own applications.

Reports

980

Serious

680

69% of reports

Hospitalization

283

Death reported

232

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death120
  • malignant neoplasm progression88
  • pneumonia74
  • off label use70
  • disease progression64
  • splenomegaly44
  • chronic lymphocytic leukaemia41
  • anaemia37
  • drug ineffective35
  • pancytopenia35
  • lymphadenopathy33
  • white blood cell count increased31
  • cytokine release syndrome29
  • platelet count decreased28
  • tumour lysis syndrome28

Reports by year received

View as table
YearReports
202217
2023117
2024173
2025286
2026387

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,179 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic lymphocytic leukaemiaSignal41187.1138.57,341
splenomegalySignal4480.960.53,380
tumour lysis syndromeSignal2868.547.51,791
cytokine release syndromeSignal2931.121.7814
lymphadenopathySignal3320.014.3578
malignant neoplasm progressionSignal8818.515.11,441
white blood cell count increasedSignal3117.412.3462
pancytopeniaSignal3513.49.7392
disease progressionSignal6411.69.2613
platelet count decreasedSignal285.63.9103
pneumoniaSignal744.93.9230
anaemiaSignal374.23.087
deathSignal1203.02.5164
off label use701.71.421
drug ineffective350.60.412

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.